Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum

被引:174
作者
Debelenko, Larisa V. [1 ]
Raimondi, Susana C. [1 ]
Daw, Najat [2 ]
Shivakumar, Bangalore R. [1 ]
Huang, Dali [3 ]
Nelson, Marilu [4 ]
Bridge, Julia A. [3 ,4 ,5 ]
机构
[1] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA
[3] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[4] Univ Nebraska Med Ctr, Dept Pediat, Meyer Munroe Inst, Omaha, NE USA
[5] Univ Nebraska Med Ctr, Dept Orthoped Surg, Omaha, NE USA
关键词
ALK; FISH; fusion gene; renal cell carcinoma; translocation; VCL; INFLAMMATORY MYOFIBROBLASTIC TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; LUNG-CANCER; YOUNG-ADULTS; KINASE GENE; VINCULIN; IDENTIFICATION; LYMPHOMA; EXPRESSION; NEUROBLASTOMA;
D O I
10.1038/modpathol.2010.213
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Renal cell carcinoma represents a model for contemporary classification of solid tumors; however, unusual and unclassifiable cases exist and are not rare in children and young adults. The anaplastic lymphoma kinase(ALK) gene has recently been implicated in subsets of pulmonary, esophageal, breast, and colon cancers. These findings strengthen the importance of molecular classification of carcinomas across different organ sites, especially considering the evolving targeted anticancer therapies with ALK inhibitors. In the current study of six pediatric renal cell carcinomas, two cases exhibited structural karyotypic abnormalities involving the ALK locus on chromosomal band 2p23. Fluorescence in situ hybridization (FISH) studies were positive for an ALK rearrangement in one case, and subsequent 5' rapid amplification of cDNA ends analysis of this tumor revealed that the 3' portion of the ALK transcript encoding for the kinase domain was fused in frame to the 5' portion of vinculin (VCL, NM_003373). The new fusion gene is predicted to have an open reading frame of 4122 bp encoding for a 1374-aa oncoprotein; its expression was shown by immunoblotting with anti-VCL and anti-ALK antibodies in tumor tissue lysates. Immunohistochemistry with the same antibodies demonstrated cytoplasmic and subplasmalemmal localization of the oncoprotein determined by its N-terminal VCL portion. FISH with a custom-designed VCL ALK dual-fusion probe set confirmed the presence of the fusion in neoplastic cells and demonstrated the potential clinical utility of this approach for detecting VCL ALK in routinely processed tissue. The five remaining pediatric renal cell carcinomas did not show ALK rearrangement by FISH or ALK expression by immunohistochemistry. The data identify the kidney as a new organ site for ALK-associated carcinomas and VCL as a novel ALK fusion partner. The results should prompt further studies to advance the molecular classification of renal cell carcinoma and help to select patients who would benefit from appropriate targeted therapies. Modern Pathology (2011) 24, 430-442; doi:10.1038/modpathol.2010.213; published online 12 November 2010
引用
收藏
页码:430 / 442
页数:13
相关论文
共 49 条
[1]   Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum [J].
Argani, Pedram ;
Olgac, Semra ;
Tickoo, Satish K. ;
Goldfischer, Michael ;
Moch, Holger ;
Chan, David Y. ;
Eble, John N. ;
Bonsib, Stephen M. ;
Jimeno, Mireya ;
Lloreta, Josep ;
Billis, Athanase ;
Hicks, Jessica ;
De Marzo, Angelo M. ;
Reuter, Victor E. ;
Ladanyi, Marc .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (08) :1149-1160
[2]   From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma [J].
Arsanious, Androu ;
Bjarnason, Georg A. ;
Yousef, George M. .
MOLECULAR CANCER, 2009, 8
[3]   Connecting cell adhesion to the actin polymerization machinery: vinculin as the missing link? [J].
Bailly, M .
TRENDS IN CELL BIOLOGY, 2003, 13 (04) :163-165
[4]   Structural basis for vinculin activation at sites of cell adhesion [J].
Bakolitsa, C ;
Cohen, DM ;
Bankston, LA ;
Bobkov, AA ;
Cadwell, GW ;
Jennings, L ;
Critchley, DR ;
Craig, SW ;
Liddington, RC .
NATURE, 2004, 430 (6999) :583-586
[5]   Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC) [J].
Bang, Y. ;
Kwak, E. L. ;
Shaw, A. T. ;
Camidge, D. R. ;
Iafrate, A. J. ;
Maki, R. G. ;
Solomon, B. J. ;
Ou, S. I. ;
Salgia, R. ;
Clark, J. W. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
[6]  
BARON BW, 1994, ACTA HAEMATOL-BASEL, V92, P119
[7]   Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor [J].
Bridge, JA ;
Kanamori, M ;
Ma, ZG ;
Pickering, D ;
Hill, DA ;
Lydiatt, W ;
Lui, MY ;
Colleoni, GWB ;
Antonescu, CR ;
Ladanyi, M ;
Morris, SW .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :411-415
[8]   Morphologic and molecular characterization of renal cell carcinoma in children and young adults [J].
Bruder, E ;
Passera, O ;
Harms, D ;
Leuschner, I ;
Ladanyi, M ;
Argani, P ;
Eble, JN ;
Struckmann, K ;
Schraml, P ;
Moch, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (09) :1117-1132
[9]   ALK+ histiocytosis:: a novel type of systemic histiocytic proliferative disorder of early infancy [J].
Chan, John K. C. ;
Lamant, Laurence ;
Algar, Elizabeth ;
Delsol, Georges ;
Tsang, William Y. W. ;
Lee, King C. ;
Tiedemann, Karin ;
Chow, Chung W. .
BLOOD, 2008, 112 (07) :2965-2968
[10]   Oncogenic mutations of ALK kinase in neuroblastoma [J].
Chen, Yuyan ;
Takita, Junko ;
Choi, Young Lim ;
Kato, Motohiro ;
Ohira, Miki ;
Sanada, Masashi ;
Wang, Lili ;
Soda, Manabu ;
Kikuchi, Akira ;
Igarashi, Takashi ;
Nakagawara, Akira ;
Hayashi, Yasuhide ;
Mano, Hiroyuki ;
Ogawa, Seishi .
NATURE, 2008, 455 (7215) :971-U56